Senestech EBITDA per osake

Mitä Senestech tekee? SenesTech, Inc. generates revenue through the sale of ContraPest, a fertility control product targeting rat populations in the pest control industry. ContraPest disrupts reproductive systems in both male and female rats, leading to contraception and eventual sterility. The company's pipeline includes feral animal fertility control for managing feral dogs and hogs in population management, non-surgical spay and neutering for companion dogs and cats in the companion animal health segment, and boar taint solutions for boars in food production and safety. These products are sold to pest control companies, animal health providers, and agricultural businesses. ContraPest is the primary revenue driver, with its application in pest control targeting rat populations. The feral animal fertility control product addresses population management needs for feral dogs and hogs, while non-surgical spay and neutering caters to companion animal health providers. Boar taint solutions are directed at food production companies seeking to improve safety and quality by addressing boar taint in boars. The company's focus on fertility control across multiple segments allows it to serve diverse clients within pest control, animal health, and food production sectors. SenesTech's revenue streams are derived from the commercialization of ContraPest and its pipeline products. ContraPest is sold to pest control businesses for managing rat infestations, while feral animal fertility control is marketed to organizations involved in managing feral animal populations. Non-surgical spay and neutering products target veterinary clinics and pet care providers, and boar taint solutions are sold to food production companies. The company's business model centers on providing fertility control solutions tailored to specific industry needs. Senestech on yksi Eurpooliin suosituimmista yhtiöistä.